Vitamin E: A theme always present, never ended;Vitamina E: Un tema siempre presente, nunca concluido

Revista Argentina de Cardiologia

Volumn 78, Issue 5, 2010, Pages 391-392

  Berg, Gabriela A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; FREE RADICAL; GAMMA TOCOTRIENOL; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TOCOPHEROL; TUMOR NECROSIS FACTOR;

EDITORIAL; ATHEROSCLEROSIS; BIOAVAILABILITY; CARCINOGENESIS; CARDIOVASCULAR DISEASE; FIBRINOGEN BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; SCIENTIFIC LITERATURE; SUBENDOTHELIUM; THROMBOCYTE AGGREGATION;

EID: 79951573310     PISSN: 00347000     EISSN: 18503748     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Galli F, Azzi A. Present trends in vitamin E research. BiofactorsBiofactors 2010;36:33-42.
2. Institute of Medicine. National Academy of Science, Food and Nutrition Board, Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. National Academy Press. Washington DC, USA. 2000.
3. Llorens C, Báez MC, Tarán M, Campana V, Fonseca I, Oyola E y col. Papel antioxidante de la vitamina E en la aterogénesis inducida por hiperfibrinogenemia. Rev Argent Cardiol 2010;78:405-10.
4. Gey KF. Ten-year retrospective on the antioxidant hypothesis of arteriosclerosis: Threshold plasma levels of antioxidant micronutrients related to minimum cardiovascular risk. J Nutr Biochem 1995;6:206-36.
5. Kaul N, Devaraj S, Jialal I. Alpha-tocopherol and atherosclerosis. Exp Biol (Maywood) 2001;226:5-12.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
7. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419-20.
8. Jackson RL, Ku G, Thomas CE. Antioxidants: a biological defense mechanism for the prevention of atherosclerosis. Med Res Rev 1993;13:161-82.
9. Kirmizis D, Chatzidimitriou D. Antiatherogenic effects of vitamin E: the search for the Holy Grail. Vasc Health Risk Manag 2009;5:767-74.
10. Devaraj S, Jialal I. Alpha-tocopherol decreases tumor necrosis factor-alpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase. Free Radic Biol Med 2005;38:1212-20.
11. Cordero Z, Drogan D, Weikert C, Boeing H. Vitamin E and risk of cardiovascular diseases: a review of epidemiologic and clinical trial studies. Crit Rev Food Sci Nutr 2010;50:420-40.
12. Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004;80:1508-20.
13. Schutte AE, Huisman HW, Oosthuizen W, van Rooyen JM, Jerling JC. Cardiovascular effects of oral supplementation of vitamin C, E and folic acid in young healthy males. Int J Vitam Nutr Res 2004;74:285-93.